CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 228	$ 112
Adjustments to reconcile net income to net cash provided by operating activities	311	392
Changes in working capital accounts, excluding the effects of acquisition	(109)	(81)
Net cash provided by operating activities	430	423
Cash flows from investing activities:
Capital expenditures	224	182
Other(1)	(5)	(8)	[1]
Net cash used in investing activities	(229)	(190)
Cash flows from financing activities:
Proceeds from issuance of senior notes and term loans	0	550
Repayments of notes and term loans (including redemption premium)	0	(562)
Payments on long-term debt	(5)	(17)
Payments of debt issuance and deferred financing costs	(4)	(8)
Payments on license obligations	(20)	(26)
Payments of contingent acquisition considerations	(16)	(9)
Purchase of L&W common stock	(219)	(145)
Purchase of SciPlay’s Class A common stock	0	(23)
Net redemptions of common stock under stock-based compensation plans and other	(51)	(11)
Net cash used in financing activities	(315)	(251)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(2)
Decrease in cash, cash equivalents and restricted cash	(114)	(20)
Cash, cash equivalents and restricted cash, beginning of period	521	967
Cash, cash equivalents and restricted cash, end of period	407	947
Supplemental cash flow information:
Cash paid for interest	208	221
Income taxes paid	118	119
Cash paid for contingent acquisition considerations included in operating activities	22	9
Supplemental non-cash transactions:
Non-cash interest expense	$ 7	$ 8

[1] (1) The nine months ended September 30, 2023 include $3 million in cash used in discontinued operations.